Shown is a diseased neuron, with disease indicated by clumpy yellow mitochondria. Scientists at Washington University School of Medicine in St. Louis and Stanford University have designed small compounds that have the potential to correct mitochondrial dysfunction that leads to Charcot-Marie-Tooth disease and other conditions involving mitochondria, the cells&#039; energy factories. (Image: G. Dorn and A. Franco)